Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Staphylococcus aureus adhesion to the human epidermis is a complex biological process rather than a single molecular target, serving as the critical initial step for bacterial colonization and subsequent infection [1]. This process is primarily mediated by a family of bacterial surface proteins known as Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs), most notably Iron-regulated surface determinant protein A (IsdA) and Clumping factor B (ClfB) [1, 2]. These bacterial proteins specifically bind to host ligands within the stratum corneum, such as loricrin, involucrin, and cytokeratin 10, which are often more accessible in patients with skin barrier defects [2, 3]. In clinical contexts like atopic dermatitis, the high density of S. aureus colonization driven by these adhesive interactions correlates with disease severity and inflammatory flares [3, 4]. Therapeutic interventions targeting this process, such as monoclonal antibodies or small-molecule inhibitors, aim to prevent the pathogen's attachment to host tissues, thereby reducing the risk of invasive infection and minimizing the disruption of the normal skin microbiome [1, 4]. While traditional antibiotics like mupirocin are used for decolonization, novel anti-adhesion strategies are being explored to provide more targeted therapy with a lower risk of promoting antimicrobial resistance [1, 3]. Sources: [1] Clarke, S. R., et al. (2007). Iron-regulated surface determinant protein A (IsdA) is needed for Staphylococcus aureus adhesion to human skin. Journal of Biological Chemistry. [2] O'Brien, L. M., et al. (2002). Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human loricrin. Molecular Microbiology. [3] Geoghegan, J. A., et al. (2018). Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship. British Journal of Dermatology. [4] Weidenmaier, C., et al. (2004). Role of teichoic acids in Staphylococcus aureus nasal colonization. Nature Medicine.
Inhibition of bacterial surface proteins (MSCRAMMs) from binding to host epidermal ligands such as loricrin, involucrin, and cytokeratin 10.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Staphylococcus aureus adhesion to human epidermis.